Target intelligence / Profile preview

Plasmodium falciparum digestive vacuole and cytosolic proteins

Molecular classification
Enzyme, Transporter, Protease, Ion channel, Other
01

Overview

The term parasite proteins in Plasmodium falciparum digestive vacuole and cytosol refers to a broad collection of molecular entities rather than a single therapeutic target. The digestive vacuole (DV) is a specialized acidic organelle where Plasmodium falciparum degrades host hemoglobin to acquire essential nutrients, a process mediated by proteases such as plasmepsins and falcipains (Goldberg, 2005, PMID: 15813510). This degradation releases toxic free heme, which the parasite must sequester into inert hemozoin crystals via heme detoxification proteins (Egan, 2008, PMID: 18514313). The cytosol contains the parasite's metabolic machinery, including enzymes for glycolysis, folate biosynthesis, and protein translation (Cowman et al., 2012, PMID: 22960356). Many antimalarial drugs, such as chloroquine and artemisinin, target specific processes within these compartments, such as heme biocrystallization or calcium homeostasis (Tilley et al., 2016, PMID: 26711511). However, because this designation encompasses hundreds of distinct proteins with diverse functions, it is considered an overly broad category for specific drug-target interaction modeling.

Other names
Plasmodium falciparum proteinsMalaria parasite proteinsP. falciparum proteome (vacuolar and cytosolic)
02

Mechanism of action

Multiple mechanisms including inhibition of heme biocrystallization, inhibition of hemoglobin-degrading proteases, disruption of parasite calcium homeostasis, and inhibition of folate synthesis.

03

Biological functions

Hemoglobin degradationHeme detoxificationMetabolismIon homeostasisProtein synthesis
04

Disease associations

Infection
05

Safety considerations

Emergence of multi-drug resistanceHemolytic toxicity in G6PD-deficient patientsNeurotoxicityCardiotoxicity (QT prolongation)
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Plasmodium falciparum histidine-rich protein 2 (PfHRP2)Plasmodium lactate dehydrogenase (pLDH)Parasite DNA

Beyond the preview

Go deeper on Plasmodium falciparum digestive vacuole and cytosolic proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum digestive vacuole and cytosolic proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call